
Epidemiology, disease burden, and treatment strategies of chronic hepatitis C virus infections in Saudi Arabia in the new treatment paradigm shift
Author(s) -
Abdulrahman Aljumah,
Faisal Abaalkhail,
Hamad I. Al-Ashgar,
Abdullah M. Assiri,
Mohammed A. Babatin,
Faleh Al Faleh,
Abdullah S Alghamdi,
Raafat F. Alhakeem,
A. Hashim,
Adel Alqutub,
Homie Razavi,
Faisal M. Sanai,
Khalid Alswat,
Jonathan Schmelzer,
Ibrahim Altraif
Publication year - 2016
Publication title -
the saudi journal of gastroenterology/saudi journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.608
H-Index - 32
eISSN - 1998-4049
pISSN - 1319-3767
DOI - 10.4103/1319-3767.187609
Subject(s) - medicine , hepatocellular carcinoma , cirrhosis , epidemiology , disease burden , liver disease , incidence (geometry) , hepatitis c , population , chronic liver disease , hepatitis c virus , disease , mortality rate , intensive care medicine , immunology , environmental health , virus , physics , optics
Around 101,000 individuals are estimated to be viremic for chronic hepatitis C virus (HCV) in the Kingdom of Saudi Arabia (KSA) in 2014; however, only about 20% have been diagnosed. We aim to assess baseline epidemiology, disease burden, and evaluate strategies to eliminate HCV in KSA.